Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Characteristics and Neutralizing Antibody Levels in a Japanese Patient with Tick-borne Encephalitis: A Case Report.

Japanese journal of infectious diseases·2026
Same author

Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

Cephalalgia : an international journal of headache·2026
Same author

Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.

Multiple sclerosis and related disorders·2026
Same author

Characterizing spinal cord atrophy in multiple sclerosis patients without disease activity or brain atrophy progression.

Multiple sclerosis and related disorders·2026
Same author

Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study.

Journal of neuroimmunology·2025

Related Experiment Video

Updated: Jun 21, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Memory and naïve B-cell subsets in patients with multiple sclerosis.

Masaaki Niino1, Makoto Hirotani, Yusei Miyazaki

  • 1Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. niino@med.hokudai.ac.jp

Neuroscience Letters
|August 12, 2009
PubMed
Summary

This study reveals distinct B-cell subset differences in multiple sclerosis (MS) patients compared to healthy individuals. Specific naïve and memory B cells, like CD86(+) and CCR5(+) naïve B cells, show potential as biomarkers for MS pathogenesis and therapy.

More Related Videos

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice
08:49

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice

Published on: October 6, 2023

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Experiment Videos

Last Updated: Jun 21, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice
08:49

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice

Published on: October 6, 2023

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Area of Science:

  • Immunology
  • Neuroimmunology
  • Cell Biology

Background:

  • Memory and naïve B cells have distinct immune regulatory roles, but their specific involvement in multiple sclerosis (MS) remains unclear.
  • Understanding these B-cell subsets in MS is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate differences in memory and naïve B-cell subsets between MS patients and healthy controls.
  • To determine the effect of interferon beta (IFNbeta)-1b on these B-cell subsets in MS patients.
  • To compare B-cell subsets during relapsing and remitting stages of MS.

Main Methods:

  • Flow cytometry was used to analyze the expression of CD5, CD80, CD86, CCR5, CXCR3, CD11a, and CD49d on memory and naïve B cells.
  • Blood samples were collected from 31 relapsing-remitting MS patients (15 treated with IFNbeta-1b, 16 untreated) and 22 healthy controls.
  • Samples were also obtained from 11 untreated patients during the relapsing stage.

Main Results:

  • Untreated MS patients showed significantly higher percentages of CD86(+) and CCR5(+) cells in the naïve B-cell subset compared to controls or IFNbeta-1b treated patients.
  • In MS patients, CD86(+) and CCR5(+) naïve B cells, and CD5(+) memory B cells were significantly higher during remission than during relapse.
  • These findings suggest a dynamic role for specific B-cell subsets in MS disease activity.

Conclusions:

  • Memory and naïve B-cell subsets, particularly CD86(+) naïve B cells, CCR5(+) naïve B cells, and CD5(+) memory B cells, are altered in multiple sclerosis.
  • These specific B-cell populations may serve as valuable indicators for studying MS pathogenesis and evaluating therapeutic responses to treatments like IFNbeta-1b.